Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Anaemia
ADR ID BADD_A00178
ADR Hierarchy
01      Blood and lymphatic system disorders
01.03      Anaemias nonhaemolytic and marrow depression
01.03.02      Anaemias NEC
01.03.02.001      Anaemia
Description A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN. [MeSH]
MedDRA Code 10002034
MeSH ID D000740
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Anaemia | Anaemia aggravated | Anaemia NOS | Anaemia NOS aggravated | Anaemia, unspecified | Anaemias, other and unspecified | Anaemic | Anemia | Anemia, unspecified | Other and unspecified anaemias | Other and unspecified anemias | Other specified anaemias | Other specified anemias | Secondary anaemia | Unspecified anemia | Anemia aggravated | Secondary anemia | Unspecified anaemia | Anemic | Anaemia post chemotherapy | Anemia post chemotherapy | Acute anemia | Acute anaemia | Chronic anaemia | Chronic anemia | Dimorphic anemia | Dimorphic anaemia | Transfusion dependent anemia | Transfusion dependent anaemia | Iatrogenic anemia | Iatrogenic anaemia | Symptomatic anemia | Symptomatic anaemia | Anemias
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01547Nefazodone hydrochloride--
BADD_D01549Nelarabine--
BADD_D01550Nelfinavir mesylate--
BADD_D01557Nevirapine0.006630%
BADD_D01558Nexium--
BADD_D01566Nifedipine--
BADD_D01567Nilotinib0.013196%
BADD_D01568Nilutamide--
BADD_D01569Nimodipine--
BADD_D01570Nisoldipine--
BADD_D01571Nitazoxanide--
BADD_D01572Nitisinone0.006469%
BADD_D01576Nitrofurantoin--
BADD_D01581Nivolumab--
BADD_D01582Nizatidine--
BADD_D01595Octreotide acetate--
BADD_D01596Ofatumumab--
BADD_D01598Ofloxacin--
BADD_D01599Olanzapine--
BADD_D01601Olaparib0.028945%
BADD_D01602Olmesartan--
BADD_D01607Olsalazine--
BADD_D01608Olsalazine sodium--
BADD_D01609Omacetaxine mepesuccinate--
BADD_D01614Omeprazole--
BADD_D01615Omeprazole magnesium--
BADD_D01617Ondansetron0.000043%
BADD_D01623Oritavancin--
BADD_D01624Orlistat0.014138%
BADD_D01627Oseltamivir--
The 18th Page    First    Pre   18 19 20 21 22    Next   Last    Total 29 Pages
ADReCS-Target
ADR Term Drug Name Target